Do tumor characteristics and prognostic factors differ between subsequent rounds of PSA screening for prostate cancer?

2007 ◽  
Vol 4 (5) ◽  
pp. 252-253
Author(s):  
Paul Maroni ◽  
E David Crawford
Keyword(s):  
Prostate Cancer ◽  
Prognostic Factors ◽  
Tumor Characteristics ◽  
Psa Screening

scholarly journals Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors

2013 ◽  
Vol 108 (10) ◽  
pp. 1971-1977 ◽  
Author(s):  
E M Wever ◽  
E A M Heijnsdijk ◽  
G Draisma ◽  
C H Bangma ◽  
M J Roobol ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prognostic Factors ◽  
Psa Screening

Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam

Urology ◽  
2006 ◽  
Vol 68 (3) ◽  
pp. 615-620 ◽  
Author(s):  
Ingrid W. van der Cruijsen-Koeter ◽  
Monique J. Roobol ◽  
Mark F. Wildhagen ◽  
T.H. van der Kwast ◽  
W.J. Kirkels ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prognostic Factors ◽  
Cancer Screening ◽  
Prostate Cancer Screening ◽  
Tumor Characteristics ◽  
Cancer Screening Trial ◽  
Screening Trial

1479: Impact of Exposure Rate of PSA-Screening on Clinical Stage of Prostate Cancer in Japan

2006 ◽  
Vol 175 (4S) ◽  
pp. 477-478 ◽  
Author(s):  
Kazuto Ito ◽  
Takumi Yamamoto ◽  
Hiroyuki Takechi ◽  
Kazuhiro Suzuki
Keyword(s):  
Prostate Cancer ◽  
Clinical Stage ◽  
Exposure Rate ◽  
Psa Screening

477: Body Mass Index and Impact on PSA Screening and Prostate Cancer Detection in the Plco Trial

2006 ◽  
Vol 175 (4S) ◽  
pp. 155-155
Author(s):  
Robert L. Grubb ◽  
David L. Levin ◽  
Paul F. Pinsky ◽  
Jerome Mabie ◽  
Thomas L. Riley ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Body Mass Index ◽  
Body Mass ◽  
Cancer Detection ◽  
Prostate Cancer Detection ◽  
Psa Screening

scholarly journals Global Trends of Latent Prostate Cancer in Autopsy Studies

Cancers ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 359
Author(s):  
Takahiro Kimura ◽  
Shun Sato ◽  
Hiroyuki Takahashi ◽  
Shin Egawa
Keyword(s):  
Prostate Cancer ◽  
Racial Differences ◽  
Specific Antigen ◽  
Tumor Location ◽  
Cancer Registration ◽  
Asian Countries ◽  
Global Trends ◽  
Psa Screening ◽  
Asian Men ◽  
Definition Of

The incidence of prostate cancer (PC) has been increasing in Asian countries, where it was previously low. Although the adoption of a Westernized lifestyle is a possible explanation, the incidence is statistically biased due to the increase in prostate-specific antigen (PSA) screening and the accuracy of national cancer registration systems. Studies on latent PC provide less biased information. This review included studies evaluating latent PC in several countries after excluding studies using random or single-section evaluations and those that did not mention section thickness. The findings showed that latent PC prevalence has been stable since 1950 in Western countries, but has increased over time in Asian countries. Latent PC in Asian men has increased in both prevalence and number of high-grade cases. Racial differences between Caucasian and Asian men may explain the tumor location of latent PC. In conclusion, the recent increase in latent PC in Asian men is consistent with an increase in clinical PC. Evidence suggests that this increase is caused not only by the increase in PSA screening, but also by the adoption of a more Westernized lifestyle. Autopsy findings suggest the need to reconsider the definition of clinically insignificant PC.

scholarly journals MP40-13 PROGNOSTIC FACTORS AND ONCOLOGIC OUTCOMES AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY IN PT3B PROSTATE CANCER

2016 ◽  
Vol 195 (4S) ◽  
Author(s):  
Dae Keun Kim ◽  
Atalla Alatawi ◽  
Abulhasan Sheikh ◽  
Ibrahim Alabdulaali ◽  
Ali Abdel Raheem ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prognostic Factors ◽  
Radical Prostatectomy ◽  
Oncologic Outcomes ◽  
Robot Assisted

Diagnostic and prognostic factors in patients with prostate cancer

2021 ◽  
Vol 79 ◽  
pp. S428-S429
Author(s):  
K. Beyer ◽  
L. Moris ◽  
M. Lardas ◽  
A. Haire ◽  
F. Barletta ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prognostic Factors

Intratibial implantation of tumor cells  v1

2021 ◽  
Author(s):  
Shubhangi Agarwal ◽  
donna.peehl not provided ◽  
Renuka Sriram
Keyword(s):  
Prostate Cancer ◽  
Cancer Patient ◽  
Metastatic Prostate Cancer ◽  
Prostate Cancer Patient ◽  
Tumor Cell Line ◽  
Small Cell ◽  
Response To Therapy ◽  
Tumor Characteristics ◽  
Patient Derived Xenograft ◽  
Neuroendocrine Prostate Cancer

This protocol describes the steps required for the successful implantation of small cell neuroendocrine prostate cancer patient-derived xenograft (PDX) cells in the bone. Bone is one of the most common sites for the development of metastatic prostate cancer and its study is important for evaluating the tumor characteristics and response to therapy. This protocol can be used for the implantation of any tumor cell line in the bone.

Sign in / Sign up

Export Citation Format

Share Document